• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 NF-κB 信号通路的中医药治疗痛风性肾病的作用机制

Therapeutic effects of traditional Chinese medicine on gouty nephropathy: Based on NF-κB signalingpathways.

机构信息

Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine, Station East 5, Shunyi District, Beijing 101300, China.

Renal Division, Department of Medicine, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.

出版信息

Biomed Pharmacother. 2023 Feb;158:114199. doi: 10.1016/j.biopha.2022.114199. Epub 2023 Jan 3.

DOI:10.1016/j.biopha.2022.114199
PMID:36916428
Abstract

As the final product of purine metabolism, excess serum uric acid (SUA) aggravates the process of some metabolic diseases. SUA causes renal tubule damage, interstitial fibrosis, and glomerular hardening, leading to gouty nephropathy (GN). A growing number of investigations have shown that NF-κB mediated inflammation and oxidative stress have been directly involved in the pathogenesis of GN. Traditional Chinese medicine's treatment methods of GN have amassed a wealth of treatment experience. In this review, we first describe the mechanism of NF-κB signaling pathways in GN. Subsequently, we highlight traditional Chinese medicine that can treat GN through NF-κB pathways. Finally, commenting on promising candidate targets of herbal medicine for GN treatment via suppressing NF-κB signaling pathways was summarized.

摘要

作为嘌呤代谢的终产物,过量的血清尿酸(SUA)会加重某些代谢疾病的进程。SUA 可导致肾小管损伤、间质纤维化和肾小球硬化,进而引发痛风性肾病(GN)。越来越多的研究表明,NF-κB 介导的炎症和氧化应激直接参与了 GN 的发病机制。中医药治疗 GN 的方法积累了丰富的治疗经验。在这篇综述中,我们首先描述了 NF-κB 信号通路在 GN 中的作用机制。随后,我们重点介绍了可通过 NF-κB 通路治疗 GN 的中药。最后,我们总结了通过抑制 NF-κB 信号通路,中草药治疗 GN 的有希望的候选靶点。

相似文献

1
Therapeutic effects of traditional Chinese medicine on gouty nephropathy: Based on NF-κB signalingpathways.基于 NF-κB 信号通路的中医药治疗痛风性肾病的作用机制
Biomed Pharmacother. 2023 Feb;158:114199. doi: 10.1016/j.biopha.2022.114199. Epub 2023 Jan 3.
2
[Modern understanding of uric acid metabolism disorders and progress in traditional Chinese medicine prevention and treatment].[尿酸代谢紊乱的现代认识与中医防治进展]
Zhongguo Zhong Yao Za Zhi. 2024 Jun;49(12):3160-3167. doi: 10.19540/j.cnki.cjcmm.20240226.501.
3
Exploring effect of herbal monomers in treating gouty arthritis based on nuclear factor-kappa B signaling: A review.基于核因子-κB 信号通路探讨中药单体治疗痛风性关节炎的作用:综述。
Medicine (Baltimore). 2024 Feb 2;103(5):e37089. doi: 10.1097/MD.0000000000037089.
4
Fufang Zhenzhu Tiaozhi capsule ameliorates hyperuricemic nephropathy by inhibition of PI3K/AKT/NF-κB pathway.复方珍珠调脂胶囊通过抑制PI3K/AKT/NF-κB通路改善高尿酸血症肾病。
J Ethnopharmacol. 2022 Nov 15;298:115644. doi: 10.1016/j.jep.2022.115644. Epub 2022 Aug 17.
5
Models of gouty nephropathy: exploring disease mechanisms and identifying potential therapeutic targets.痛风性肾病模型:探索疾病机制并确定潜在治疗靶点。
Front Med (Lausanne). 2024 Feb 29;11:1305431. doi: 10.3389/fmed.2024.1305431. eCollection 2024.
6
Combination of active components of Xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/Smad pathways in db/db diabetic mice.泻心汤活性成分组合通过抑制db/db糖尿病小鼠的NF-κB和TGF-β1/Smad信号通路改善肾纤维化。
PLoS One. 2015 Mar 24;10(3):e0122661. doi: 10.1371/journal.pone.0122661. eCollection 2015.
7
Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB.尿酸通过至少两条涉及蛋白激酶C(PKC)、丝裂原活化蛋白激酶(MAPK)、胞浆型磷脂酶A2(cPLA2)和核因子κB(NF-κB)的信号通路抑制肾近端小管细胞增殖。
Am J Physiol Renal Physiol. 2007 Jan;292(1):F373-81. doi: 10.1152/ajprenal.00104.2006. Epub 2006 Sep 19.
8
Uric acid induces renal inflammation via activating tubular NF-κB signaling pathway.尿酸通过激活肾小管 NF-κB 信号通路诱导肾脏炎症。
PLoS One. 2012;7(6):e39738. doi: 10.1371/journal.pone.0039738. Epub 2012 Jun 25.
9
Galangin Suppresses Renal Inflammation via the Inhibition of NF-B, PI3K/AKT and NLRP3 in Uric Acid Treated NRK-52E Tubular Epithelial Cells.姜黄素通过抑制 NF-B、PI3K/AKT 和尿酸处理的 NRK-52E 肾小管上皮细胞中的 NLRP3 抑制肾脏炎症。
Biomed Res Int. 2019 May 26;2019:3018357. doi: 10.1155/2019/3018357. eCollection 2019.
10
Emodinol ameliorates urate nephropathy by regulating renal organic ion transporters and inhibiting immune inflammatory responses in rats.依诺肝素通过调节肾脏有机离子转运体和抑制免疫炎症反应改善大鼠尿酸肾病。
Biomed Pharmacother. 2017 Dec;96:727-735. doi: 10.1016/j.biopha.2017.10.051. Epub 2017 Nov 6.

引用本文的文献

1
A Mendelian randomization study of serum uric acid in metabolic and cardiovascular risk in East Asian populations.东亚人群中血清尿酸与代谢及心血管风险的孟德尔随机化研究。
Medicine (Baltimore). 2025 Sep 5;104(36):e44135. doi: 10.1097/MD.0000000000044135.
2
Structural Characterization and Anti-Gouty Nephropathy Potential of Polysaccharides from ..来源多糖的结构表征及抗痛风性肾病潜力
Molecules. 2025 Feb 7;30(4):757. doi: 10.3390/molecules30040757.
3
Global research progress and trends in traditional Chinese medicine for chronic kidney disease since the 21st century: a bibliometric analysis.
21世纪以来中医治疗慢性肾脏病的全球研究进展与趋势:一项文献计量分析
Front Med (Lausanne). 2025 Jan 17;11:1480832. doi: 10.3389/fmed.2024.1480832. eCollection 2024.
4
Scutellarein Inhibits Osteosarcoma Growth by Targeting the TLR4/TRAF6/NF-κB Pathway.野黄芩苷通过靶向TLR4/TRAF6/NF-κB信号通路抑制骨肉瘤生长。
Drug Des Devel Ther. 2025 Jan 6;19:51-64. doi: 10.2147/DDDT.S489092. eCollection 2025.
5
The Role of Antioxidant Transcription Factor Nrf2 and Its Activating Compounds in Systemic Lupus Erythematosus.抗氧化转录因子Nrf2及其激活化合物在系统性红斑狼疮中的作用
Antioxidants (Basel). 2024 Oct 11;13(10):1224. doi: 10.3390/antiox13101224.
6
Cell-cell communication: new insights and clinical implications.细胞间通讯:新的见解和临床意义。
Signal Transduct Target Ther. 2024 Aug 7;9(1):196. doi: 10.1038/s41392-024-01888-z.
7
Models of gouty nephropathy: exploring disease mechanisms and identifying potential therapeutic targets.痛风性肾病模型:探索疾病机制并确定潜在治疗靶点。
Front Med (Lausanne). 2024 Feb 29;11:1305431. doi: 10.3389/fmed.2024.1305431. eCollection 2024.